Wealth Enhancement Advisory Services LLC Has $592,000 Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Wealth Enhancement Advisory Services LLC lifted its stake in Teleflex Incorporated (NYSE:TFX) by 4.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,329 shares of the medical technology company’s stock after acquiring an additional 152 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Teleflex were worth $592,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of TFX. Siemens Fonds Invest GmbH bought a new position in Teleflex in the 4th quarter valued at approximately $1,336,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Teleflex in the 4th quarter valued at $6,528,000. Jefferies Financial Group Inc. boosted its position in shares of Teleflex by 9.3% during the 4th quarter. Jefferies Financial Group Inc. now owns 4,837 shares of the medical technology company’s stock worth $861,000 after purchasing an additional 412 shares in the last quarter. Mackenzie Financial Corp raised its position in shares of Teleflex by 59.2% during the fourth quarter. Mackenzie Financial Corp now owns 36,281 shares of the medical technology company’s stock worth $6,457,000 after purchasing an additional 13,488 shares during the period. Finally, Forum Financial Management LP increased its holdings in Teleflex by 48.6% during the 4th quarter. Forum Financial Management LP now owns 1,293 shares of the medical technology company’s stock worth $230,000 after purchasing an additional 423 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 2.4%

Shares of TFX stock opened at $122.47 on Thursday. Teleflex Incorporated has a 1-year low of $118.70 and a 1-year high of $249.91. The company has a market cap of $5.41 billion, a price-to-earnings ratio of 24.35, a price-to-earnings-growth ratio of 1.73 and a beta of 1.10. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock’s fifty day moving average price is $127.06 and its 200 day moving average price is $153.67.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping analysts’ consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company’s revenue was down 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.21 earnings per share. On average, research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex’s dividend payout ratio is presently 42.90%.

Analysts Set New Price Targets

A number of brokerages have issued reports on TFX. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Morgan Stanley cut their price target on shares of Teleflex from $191.00 to $173.00 and set an “overweight” rating for the company in a report on Monday, May 5th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. Bank of America lowered shares of Teleflex from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Finally, Royal Bank of Canada lowered their price objective on Teleflex from $150.00 to $145.00 and set a “sector perform” rating for the company in a research report on Friday, May 2nd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.